CIK 0001623526 · Non-accelerated filer<br>Smaller reporting company
Stoke Therapeutics, Inc.
Sign in to watch- Ticker
- STOK
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 471144582
- Phone
- 781-430-8200
- Business address
- 45 WIGGINS AVENUE, BEDFORD, MA, 01730
- Former names
- ASOthera Pharmaceuticals, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,050,832
- in 7 filings, $404K under 10b5-1 plans
Net −$1,050,832. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-03 | Ticho Barry CHIEF MEDICAL OFFICER | Sale 10b5-1 | −1,269 | $29.45 | $37K | 20,422 |
| 2026-07-16 | Harrison Seth Loring Director | Gift · Stock Option (Right to Buy) | −29,555 | 0 | ||
| 2026-07-16 | Harrison Seth Loring Director | Gift · Stock Option (Right to Buy) | +29,555 | 29,555 | ||
| 2026-07-16 | Harrison Seth Loring Director | Gift · Stock Option (Right to Buy) | −14,777 | 0 | ||
| 2026-07-16 | Harrison Seth Loring Director | Gift · Stock Option (Right to Buy) | +14,777 | 14,777 | ||
| 2026-07-16 | Harrison Seth Loring Director | Gift · Stock Option (Right to Buy) | −11,650 | 0 | ||
| 2026-07-16 | Harrison Seth Loring Director | Gift · Stock Option (Right to Buy) | +11,650 | 11,650 | ||
| 2026-07-16 | Harrison Seth Loring Director | Gift · Stock Option (Right to Buy) | −21,000 | 0 | ||
| 2026-07-16 | Harrison Seth Loring Director | Gift · Stock Option (Right to Buy) | +21,000 | 21,000 | ||
| 2026-07-16 | Harrison Seth Loring Director | Gift · Stock Option (Right to Buy) | −19,441 | 0 | ||
| 2026-07-16 | Harrison Seth Loring Director | Gift · Stock Option (Right to Buy) | +19,441 | 19,441 | ||
| 2026-07-16 | Harrison Seth Loring Director | Gift · Stock Option (Right to Buy) | −7,639 | 0 | ||
| 2026-07-16 | Harrison Seth Loring Director | Gift · Stock Option (Right to Buy) | +7,639 | 7,639 | ||
| 2026-07-16 | Harrison Seth Loring Director | Gift · Stock Option (Right to Buy) | −29,747 | 0 | ||
| 2026-07-16 | Harrison Seth Loring Director | Gift · Stock Option (Right to Buy) | +29,747 | 29,747 | ||
| 2026-07-16 | Harrison Seth Loring Director | Gift · Stock Option (Right to Buy) | −17,786 | 0 | ||
| 2026-07-16 | Harrison Seth Loring Director | Gift · Stock Option (Right to Buy) | +17,786 | 17,786 | ||
| 2026-07-15 | McCauley Thomas Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +225,000 | 225,000 | ||
| 2026-07-01 | Ticho Barry CHIEF MEDICAL OFFICER | Sale 10b5-1 | −6,728 | $32.62 | $219K | 28,098 |
| 2026-07-01 | Ticho Barry CHIEF MEDICAL OFFICER | Sale 10b5-1 | −500 | $33.27 | $17K | 27,598 |
Page 2 of 13 · 256 trades